6 Andreas Halvorsen Inhibrx Trades
Andreas Halvorsen acquired 7.15 Million Inhibrx shares worth $248 Million. That's 0.94% of their equity portfolio (35th largest holding). The investor owns 13.65% of the outstanding Inhibrx stock. The first Inhibrx trade was made in Q3 2020. Since then Andreas Halvorsen bought shares three more times and sold shares on two occasions. The stake costed the investor $161 Million, netting the investor a gain of 54% so far.
Avg closing price
Price range
Increased shares by 84.4% (+3.27 Million shares)
Q3 2023
Avg closing price
$20.92
Price range
$15.75
-
$26.31
Sold 41.6% shares (-2.76 Million shares)
Aug 28, 2023
Avg closing price
$19.35
Price range
$19.35
-
$19.35
Increased shares by 71.2% (+2.76 Million shares)
Q4 2022
Avg closing price
$29.39
Price range
$20.18
-
$33.33
Sold 26.9% shares (-1.43 Million shares)
Oct 07, 2022
Avg closing price
$30.50
Price range
$30.50
-
$30.50
Increased shares by 36.8% (+1.43 Million shares)
Q3 2020
Avg closing price
$18.12
Price range
$16.77
-
$20.65
New holding (+3.88 Million shares)
Aug 21, 2020
Avg closing price
$20.43
Price range
$20.43
-
$20.43
